ProKidney Corp.
PROK
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$1.94
FAIR PRICE
$2.44
MARGIN
$0.50
P/E Ratio
N/A
Div. Yield
N/A
ROE
13.4%
Market Cap
$242M
Small-cap
COMING SOON
Get notified when PROK's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Bruce Culleton
COUNTRY
US
HEADQUARTERS
Winston-Salem
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate PROK's fair price
ProKidney Corp.'s fair price of $2.44 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $1.94, PROK trades 25.8% below its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting PROK's risk profile.
RELATIVE · 30%
Comparing PROK's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for PROK, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for PROK.
Explore on BuliosFAQ
What is the fair price of PROK?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for ProKidney Corp. is $2.44. At the current market price of $1.94, PROK trades 25.8% below its calculated fair value.
Is PROK overvalued or undervalued?+
ProKidney Corp. is currently undervalued based on our valuation model. The stock trades at $1.94, which is 25.8% below the fair price of $2.44.
How often is PROK's fair price updated?+
We update fair price calculations for PROK daily after market close. The current fair price of $2.44 incorporates the latest market data and sector multiples.
What factors affect PROK's fair price calculation?+
PROK's fair price of $2.44 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 13.4%.
Is PROK a good buy right now?+
At $1.94, PROK trades 25.8% below our fair value estimate of $2.44. The stock is currently undervalued. ROE stands at 13.4% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does PROK pay dividends?+
PROK does not currently pay a dividend.